07-Feb-2020 13:24:17 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

07-Feb-2020 13:24:17 Start input checks
07-Feb-2020 13:24:17 Prepare population: Sick_adults_400mg_sd! 

07-Feb-2020 13:24:26 Organism|BSA was added to population
07-Feb-2020 13:24:27 GFR parameter were added to population
07-Feb-2020 13:24:27 GFR norm parameter was added to population
07-Feb-2020 13:24:27 fraction unbound was added to population
07-Feb-2020 13:24:27 Applicationprotocol
07-Feb-2020 13:24:27   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
07-Feb-2020 13:24:31 Prepare population: Healthy_adults_400mg_sd! 

07-Feb-2020 13:24:40 Organism|BSA was added to population
07-Feb-2020 13:24:40 GFR parameter were added to population
07-Feb-2020 13:24:40 GFR norm parameter was added to population
07-Feb-2020 13:24:40 fraction unbound was added to population
07-Feb-2020 13:24:40 Applicationprotocol
07-Feb-2020 13:24:40   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
07-Feb-2020 13:24:44 Input checks were successfully executed. 
)
07-Feb-2020 13:24:44 Start Simulation of Sick_adults_400mg_sd
07-Feb-2020 13:25:59 Simulation finished 

07-Feb-2020 13:25:59 Start Simulation of Healthy_adults_400mg_sd
07-Feb-2020 13:27:14 Simulation finished 

07-Feb-2020 13:27:14 Calculate PK Parameter of Sick_adults_400mg_sd
07-Feb-2020 13:27:15 Calculation finished 

07-Feb-2020 13:27:15 Calculate PK Parameter of Healthy_adults_400mg_sd
07-Feb-2020 13:27:15 Calculation finished 

07-Feb-2020 13:27:15 Start Population VPC
07-Feb-2020 13:28:10 Finalized Population VPC 

07-Feb-2020 13:28:10 Population workflow finalized 

07-Feb-2020 17:34:09 Restart:
07-Feb-2020 17:34:09 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

07-Feb-2020 17:34:09 Start input checks
07-Feb-2020 17:34:09 Prepare population: Sick_adults_400mg_sd! 

07-Feb-2020 17:34:18 Organism|BSA was added to population
07-Feb-2020 17:34:18 GFR parameter were added to population
07-Feb-2020 17:34:18 GFR norm parameter was added to population
07-Feb-2020 17:34:19 fraction unbound was added to population
07-Feb-2020 17:34:19 Applicationprotocol
07-Feb-2020 17:34:19   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
07-Feb-2020 17:34:23 Prepare population: Healthy_adults_400mg_sd! 

07-Feb-2020 17:34:32 Organism|BSA was added to population
07-Feb-2020 17:34:32 GFR parameter were added to population
07-Feb-2020 17:34:32 GFR norm parameter was added to population
07-Feb-2020 17:34:32 fraction unbound was added to population
07-Feb-2020 17:34:33 Applicationprotocol
07-Feb-2020 17:34:33   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
07-Feb-2020 17:34:37 Input checks were successfully executed. 
)
07-Feb-2020 17:34:37 start sensitivity analysis
07-Feb-2020 17:34:37 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
07-Feb-2020 17:34:37 start simulations for percentile 5 individual ID 22 with 20 simulations
07-Feb-2020 17:35:01 sensitivity analysis finished with error 

07-Feb-2020 17:35:01 Population workflow finalized 

07-Feb-2020 17:38:44 Restart:
07-Feb-2020 17:38:44 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

07-Feb-2020 17:38:44 Start input checks
07-Feb-2020 17:38:44 Prepare population: Sick_adults_400mg_sd! 

07-Feb-2020 17:38:53 Organism|BSA was added to population
07-Feb-2020 17:38:53 GFR parameter were added to population
07-Feb-2020 17:38:53 GFR norm parameter was added to population
07-Feb-2020 17:38:53 fraction unbound was added to population
07-Feb-2020 17:38:53 Applicationprotocol
07-Feb-2020 17:38:53   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
07-Feb-2020 17:38:58 Prepare population: Healthy_adults_400mg_sd! 

07-Feb-2020 17:39:06 Organism|BSA was added to population
07-Feb-2020 17:39:07 GFR parameter were added to population
07-Feb-2020 17:39:07 GFR norm parameter was added to population
07-Feb-2020 17:39:07 fraction unbound was added to population
07-Feb-2020 17:39:07 Applicationprotocol
07-Feb-2020 17:39:07   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
07-Feb-2020 17:39:11 Input checks were successfully executed. 
)
07-Feb-2020 17:39:11 start sensitivity analysis
07-Feb-2020 17:39:11 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
07-Feb-2020 17:39:11 start simulations for percentile 5 individual ID 22 with 20 simulations
07-Feb-2020 17:39:35 sensitivity analysis finished with error 

07-Feb-2020 17:39:35 Population workflow finalized 

07-Feb-2020 17:42:18 Restart:
07-Feb-2020 17:42:18 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

07-Feb-2020 17:42:18 Start input checks
07-Feb-2020 17:42:18 Prepare population: Sick_adults_400mg_sd! 

07-Feb-2020 17:42:27 Organism|BSA was added to population
07-Feb-2020 17:42:28 GFR parameter were added to population
07-Feb-2020 17:42:28 GFR norm parameter was added to population
07-Feb-2020 17:42:28 fraction unbound was added to population
07-Feb-2020 17:42:28 Applicationprotocol
07-Feb-2020 17:42:28   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
07-Feb-2020 17:42:32 Prepare population: Healthy_adults_400mg_sd! 

07-Feb-2020 17:42:40 Organism|BSA was added to population
07-Feb-2020 17:42:41 GFR parameter were added to population
07-Feb-2020 17:42:41 GFR norm parameter was added to population
07-Feb-2020 17:42:41 fraction unbound was added to population
07-Feb-2020 17:42:41 Applicationprotocol
07-Feb-2020 17:42:41   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
07-Feb-2020 17:42:45 Input checks were successfully executed. 
)
07-Feb-2020 17:42:45 start sensitivity analysis
07-Feb-2020 17:42:45 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
07-Feb-2020 17:42:45 start simulations for percentile 5 individual ID 22 with 20 simulations
07-Feb-2020 17:43:08 sensitivity analysis finished with error 

07-Feb-2020 17:43:08 Population workflow finalized 

10-Feb-2020 08:52:29 Restart:
10-Feb-2020 08:52:29 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

10-Feb-2020 08:52:29 Start input checks
10-Feb-2020 08:52:29 Prepare population: Sick_adults_400mg_sd! 

10-Feb-2020 08:52:37 Organism|BSA was added to population
10-Feb-2020 08:52:37 GFR parameter were added to population
10-Feb-2020 08:52:37 GFR norm parameter was added to population
10-Feb-2020 08:52:37 fraction unbound was added to population
10-Feb-2020 08:52:37 Applicationprotocol
10-Feb-2020 08:52:37   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 08:52:40 Prepare population: Healthy_adults_400mg_sd! 

10-Feb-2020 08:52:48 Organism|BSA was added to population
10-Feb-2020 08:52:49 GFR parameter were added to population
10-Feb-2020 08:52:49 GFR norm parameter was added to population
10-Feb-2020 08:52:49 fraction unbound was added to population
10-Feb-2020 08:52:49 Applicationprotocol
10-Feb-2020 08:52:49   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 08:52:52 Input checks were successfully executed. 
)
10-Feb-2020 08:52:52 start sensitivity analysis
10-Feb-2020 08:52:52 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
10-Feb-2020 08:52:52 start simulations for percentile 5 individual ID 22 with 20 simulations
10-Feb-2020 08:53:13 sensitivity analysis finished with error 

10-Feb-2020 08:53:13 Population workflow finalized 

10-Feb-2020 08:54:22 Restart:
10-Feb-2020 08:54:22 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

10-Feb-2020 08:54:22 Start input checks
10-Feb-2020 08:54:22 Prepare population: Sick_adults_400mg_sd! 

10-Feb-2020 08:54:30 Organism|BSA was added to population
10-Feb-2020 08:54:30 GFR parameter were added to population
10-Feb-2020 08:54:30 GFR norm parameter was added to population
10-Feb-2020 08:54:30 fraction unbound was added to population
10-Feb-2020 08:54:30 Applicationprotocol
10-Feb-2020 08:54:30   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 08:54:34 Prepare population: Healthy_adults_400mg_sd! 

10-Feb-2020 08:54:41 Organism|BSA was added to population
10-Feb-2020 08:54:41 GFR parameter were added to population
10-Feb-2020 08:54:41 GFR norm parameter was added to population
10-Feb-2020 08:54:42 fraction unbound was added to population
10-Feb-2020 08:54:42 Applicationprotocol
10-Feb-2020 08:54:42   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 08:54:45 Input checks were successfully executed. 
)
10-Feb-2020 08:54:45 start sensitivity analysis
10-Feb-2020 08:54:45 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
10-Feb-2020 08:54:45 start simulations for percentile 5 individual ID 22 with 20 simulations
10-Feb-2020 08:55:06 sensitivity analysis finished with error 

10-Feb-2020 08:55:06 Population workflow finalized 

10-Feb-2020 08:57:41 Restart:
10-Feb-2020 08:57:41 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

10-Feb-2020 08:57:41 Start input checks
10-Feb-2020 08:57:41 Prepare population: Sick_adults_400mg_sd! 

10-Feb-2020 08:57:49 Organism|BSA was added to population
10-Feb-2020 08:57:49 GFR parameter were added to population
10-Feb-2020 08:57:49 GFR norm parameter was added to population
10-Feb-2020 08:57:49 fraction unbound was added to population
10-Feb-2020 08:57:49 Applicationprotocol
10-Feb-2020 08:57:49   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 08:57:52 Prepare population: Healthy_adults_400mg_sd! 

10-Feb-2020 08:58:00 Organism|BSA was added to population
10-Feb-2020 08:58:00 GFR parameter were added to population
10-Feb-2020 08:58:00 GFR norm parameter was added to population
10-Feb-2020 08:58:00 fraction unbound was added to population
10-Feb-2020 08:58:00 Applicationprotocol
10-Feb-2020 08:58:00   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 08:58:03 Input checks were successfully executed. 
)
10-Feb-2020 08:58:03 start sensitivity analysis
10-Feb-2020 08:58:03 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
10-Feb-2020 08:58:04 start simulations for percentile 5 individual ID 22 with 20 simulations
10-Feb-2020 08:58:25 sensitivity analysis finished with error 

10-Feb-2020 08:58:25 Population workflow finalized 

10-Feb-2020 09:03:43 Restart:
10-Feb-2020 09:03:43 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

10-Feb-2020 09:03:43 Start input checks
10-Feb-2020 09:03:43 Prepare population: Sick_adults_400mg_sd! 

10-Feb-2020 09:03:50 Organism|BSA was added to population
10-Feb-2020 09:03:51 GFR parameter were added to population
10-Feb-2020 09:03:51 GFR norm parameter was added to population
10-Feb-2020 09:03:51 fraction unbound was added to population
10-Feb-2020 09:03:51 Applicationprotocol
10-Feb-2020 09:03:51   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 09:03:54 Prepare population: Healthy_adults_400mg_sd! 

10-Feb-2020 09:04:02 Organism|BSA was added to population
10-Feb-2020 09:04:02 GFR parameter were added to population
10-Feb-2020 09:04:02 GFR norm parameter was added to population
10-Feb-2020 09:04:02 fraction unbound was added to population
10-Feb-2020 09:04:02 Applicationprotocol
10-Feb-2020 09:04:02   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 09:04:05 Input checks were successfully executed. 
)
10-Feb-2020 09:04:05 start sensitivity analysis
10-Feb-2020 09:04:05 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
10-Feb-2020 09:04:05 start simulations for percentile 5 individual ID 22 with 20 simulations
10-Feb-2020 09:04:26 sensitivity analysis finished with error 

10-Feb-2020 09:04:26 Population workflow finalized 

10-Feb-2020 09:09:31 Restart:
10-Feb-2020 09:09:31 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

10-Feb-2020 09:09:31 Start input checks
10-Feb-2020 09:09:31 Prepare population: Sick_adults_400mg_sd! 

10-Feb-2020 09:09:39 Organism|BSA was added to population
10-Feb-2020 09:09:39 GFR parameter were added to population
10-Feb-2020 09:09:39 GFR norm parameter was added to population
10-Feb-2020 09:09:39 fraction unbound was added to population
10-Feb-2020 09:09:39 Applicationprotocol
10-Feb-2020 09:09:39   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 09:09:42 Prepare population: Healthy_adults_400mg_sd! 

10-Feb-2020 09:09:50 Organism|BSA was added to population
10-Feb-2020 09:09:50 GFR parameter were added to population
10-Feb-2020 09:09:50 GFR norm parameter was added to population
10-Feb-2020 09:09:50 fraction unbound was added to population
10-Feb-2020 09:09:50 Applicationprotocol
10-Feb-2020 09:09:50   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 09:09:53 Input checks were successfully executed. 
)
10-Feb-2020 09:09:53 start sensitivity analysis
10-Feb-2020 09:09:53 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
10-Feb-2020 09:09:53 start simulations for percentile 5 individual ID 22 with 20 simulations
10-Feb-2020 09:10:14 sensitivity analysis finished with error 

10-Feb-2020 09:10:14 Population workflow finalized 

10-Feb-2020 09:11:56 Restart:
10-Feb-2020 09:11:56 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

10-Feb-2020 09:11:57 Start input checks
10-Feb-2020 09:11:57 Prepare population: Sick_adults_400mg_sd! 

10-Feb-2020 09:12:04 GFR parameter were added to population
10-Feb-2020 09:12:05 GFR norm parameter was added to population
10-Feb-2020 09:12:05 fraction unbound was added to population
10-Feb-2020 09:12:05 Applicationprotocol
10-Feb-2020 09:12:05   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 09:12:08 Prepare population: Healthy_adults_400mg_sd! 

10-Feb-2020 09:12:15 GFR parameter were added to population
10-Feb-2020 09:12:16 GFR norm parameter was added to population
10-Feb-2020 09:12:16 fraction unbound was added to population
10-Feb-2020 09:12:16 Applicationprotocol
10-Feb-2020 09:12:16   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 10:41:38 Restart:
10-Feb-2020 10:41:38 Start Workflow:  Population workflow, mode ratioComparison 
 System is validated 
 Computer XXXXX (PCWIN64) 
 Reporting Engine version: 2.1 
 Open Systems Pharmacology Suite version: 7.2 
 Version of SimModel: 2.2 
 SimModelCompName: OSPSuite_SimModelComp.xml 
 Matlab version: 9.3.0.713579 (R2017b) 
 Started by: XXXXX 

10-Feb-2020 10:41:38 Start input checks
10-Feb-2020 10:41:38 Prepare population: Sick_adults_400mg_sd! 

10-Feb-2020 10:41:46 Organism|BSA was added to population
10-Feb-2020 10:41:46 GFR parameter were added to population
10-Feb-2020 10:41:46 GFR norm parameter was added to population
10-Feb-2020 10:41:46 fraction unbound was added to population
10-Feb-2020 10:41:47 Applicationprotocol
10-Feb-2020 10:41:47   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 10:41:50 Prepare population: Healthy_adults_400mg_sd! 

10-Feb-2020 10:41:58 Organism|BSA was added to population
10-Feb-2020 10:41:58 GFR parameter were added to population
10-Feb-2020 10:41:58 GFR norm parameter was added to population
10-Feb-2020 10:41:58 fraction unbound was added to population
10-Feb-2020 10:41:58 Applicationprotocol
10-Feb-2020 10:41:58   Iwamoto 2008 400mg PO (Figure 1) omeprazole study|filmcoated tablet (original Merck formulation)|Application_1: start time 0 min; dose 400 mg; infusion time 0 min
10-Feb-2020 10:42:01 Input checks were successfully executed. 
)
10-Feb-2020 10:42:01 start sensitivity analysis
10-Feb-2020 10:42:01 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max
10-Feb-2020 10:42:01 start simulations for percentile 5 individual ID 22 with 20 simulations
10-Feb-2020 10:42:22 start simulations for percentile 50 individual ID 48 with 20 simulations
10-Feb-2020 10:42:41 start simulations for percentile 95 individual ID 79 with 20 simulations
10-Feb-2020 10:43:04 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_max_norm
10-Feb-2020 10:43:04 start simulations for percentile 5 individual ID 7 with 20 simulations
10-Feb-2020 10:43:24 start simulations for percentile 50 individual ID 49 with 20 simulations
10-Feb-2020 10:43:45 start simulations for percentile 95 individual ID 5 with 20 simulations
10-Feb-2020 10:44:08 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir t_max
10-Feb-2020 10:44:08 start simulations for percentile 5 individual ID 12 with 20 simulations
10-Feb-2020 10:44:28 start simulations for percentile 50 individual ID 5 with 20 simulations
10-Feb-2020 10:44:47 start simulations for percentile 95 individual ID 7 with 20 simulations
10-Feb-2020 10:45:12 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir C_tEnd
10-Feb-2020 10:45:12 start simulations for percentile 5 individual ID 45 with 20 simulations
10-Feb-2020 10:45:31 start simulations for percentile 50 individual ID 11 with 20 simulations
10-Feb-2020 10:45:50 start simulations for percentile 95 individual ID 17 with 20 simulations
10-Feb-2020 10:46:15 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir AUC
10-Feb-2020 10:46:15 start simulations for percentile 5 individual ID 37 with 20 simulations
10-Feb-2020 10:46:34 start simulations for percentile 50 individual ID 49 with 20 simulations
10-Feb-2020 10:46:54 start simulations for percentile 95 individual ID 41 with 20 simulations
10-Feb-2020 10:47:17 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir AUC_norm
10-Feb-2020 10:47:17 start simulations for percentile 5 individual ID 91 with 20 simulations
10-Feb-2020 10:47:36 start simulations for percentile 50 individual ID 68 with 20 simulations
10-Feb-2020 10:47:55 start simulations for percentile 95 individual ID 9 with 20 simulations
10-Feb-2020 10:48:18 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir AUC_inf
10-Feb-2020 10:48:18 start simulations for percentile 5 individual ID 37 with 20 simulations
10-Feb-2020 10:48:38 start simulations for percentile 50 individual ID 47 with 20 simulations
10-Feb-2020 10:48:57 start simulations for percentile 95 individual ID 41 with 20 simulations
10-Feb-2020 10:49:20 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir AUC_inf_norm
10-Feb-2020 10:49:20 start simulations for percentile 5 individual ID 58 with 20 simulations
10-Feb-2020 10:49:39 start simulations for percentile 50 individual ID 59 with 20 simulations
10-Feb-2020 10:49:58 start simulations for percentile 95 individual ID 24 with 20 simulations
10-Feb-2020 10:50:21 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir MRT
10-Feb-2020 10:50:21 start simulations for percentile 5 individual ID 38 with 20 simulations
10-Feb-2020 10:50:40 start simulations for percentile 50 individual ID 28 with 20 simulations
10-Feb-2020 10:51:01 start simulations for percentile 95 individual ID 78 with 20 simulations
10-Feb-2020 10:51:25 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir Thalf
10-Feb-2020 10:51:25 start simulations for percentile 5 individual ID 63 with 20 simulations
10-Feb-2020 10:51:46 start simulations for percentile 50 individual ID 83 with 20 simulations
10-Feb-2020 10:52:06 start simulations for percentile 95 individual ID 93 with 20 simulations
10-Feb-2020 10:52:29 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir CL
10-Feb-2020 10:52:29 start simulations for percentile 5 individual ID 9 with 20 simulations
10-Feb-2020 10:52:49 start simulations for percentile 50 individual ID 59 with 20 simulations
10-Feb-2020 10:53:08 start simulations for percentile 95 individual ID 58 with 20 simulations
10-Feb-2020 10:53:32 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir Vss
10-Feb-2020 10:53:32 start simulations for percentile 5 individual ID 50 with 20 simulations
10-Feb-2020 10:53:52 start simulations for percentile 50 individual ID 49 with 20 simulations
10-Feb-2020 10:54:12 start simulations for percentile 95 individual ID 51 with 20 simulations
10-Feb-2020 10:54:36 start sensitivity simulation for Sick_adults_400mg_sd, Raltegravir Vd
10-Feb-2020 10:54:36 start simulations for percentile 5 individual ID 30 with 20 simulations
10-Feb-2020 10:54:57 start simulations for percentile 50 individual ID 61 with 20 simulations
10-Feb-2020 10:55:17 start simulations for percentile 95 individual ID 93 with 20 simulations
10-Feb-2020 10:55:39 finalize sensitivity analysis
10-Feb-2020 10:55:39 Population workflow finalized 

